Experts call for change to vaccine protocols for pregnant women

The scientific community must better include the interests of pregnant women in vaccine development and deployment, according to a new report from the Pregnancy Research Ethics for Vaccines, Epidemics and New Technologies Working Group.

Advertisement

The PREVENT Working Group is a grant-funded project led by faculty at Baltimore-based Johns Hopkins University, along with researchers at Washington, D.C.-based Georgetown University and the University of North Carolina at Chapel Hill.

The group issued a report Dec. 6 arguing pregnant and lactating women should be included in more vaccine studies and surveillance efforts to protect them and their children from emerging infectious diseases.

The 96-page report outlines numerous recommendations to help ensure pregnant women can benefit from vaccine advancements, such as strengthening infectious disease surveillance systems to include relevant data on maternal, obstetric and newborn health outcomes.

To view the full report, click here.

More articles on clinical leadership & infection control:
5 key strategies to mitigate the effect of antimicrobial resistance
Infections raise risk of mental disorders in kids
Errors in use of antibiotics, blood thinners among most common leading to death

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.